GlassScriptPhysician profile
Rochelle Pena
NPI 1598235269
$983.99
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $226 · 2022: $249 · 2023: $426 · 2024: $83.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202.55 | 2021-2024 | |
| Medtronic, INC. | $76.71 | 2023 | Synchromedii |
| Boston Scientific Corporation | $68.75 | 2021-2023 | |
| Abbott Laboratories | $66.17 | 2022 | |
| Lilly USA, LLC | $58.89 | 2021-2022 | |
| Biogen, INC. | $56.28 | 2023 | Spinraza |
| Novo Nordisk INC | $52.71 | 2022 | |
| Insightec,INC | $44.49 | 2023 | Exablate |
| Gilead Sciences, INC. | $39.84 | 2022 | |
| Glaxosmithkline, LLC. | $30.98 | 2021 | |
| Ironwood Pharmaceuticals, INC | $27.32 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.78 | 2021-2024 | Airsupra |
| Pfizer INC. | $25.62 | 2021 | |
| Kaleo, INC. | $22.54 | 2022 | |
| Astellas Pharma US INC | $21.97 | 2023 | Veozah |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $20.61 | 2023 | Heplisav-B |
| Phadia US INC. | $18.33 | 2023 | Immunocap |
| Amgen INC. | $17.84 | 2021 | |
| Hologic Sales and Service, LLC | $16.95 | 2024 | Aptima |
| Intra-Sana Laboratories | $16.38 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Sanofi-Aventis U.S. LLC | $16.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.40 | 2021 | |
| Lucid Diagnostics INC. | $15.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.58 | 2022 | |
| Exact Sciences Corporation | $13.08 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rochelle Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.